Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

Similar articles for PubMed (Select 6787100)

1.

Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study.

Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC Jr.

J Am Acad Dermatol. 1981 Jun;4(6):698-710.

PMID:
6787100
2.

Melasma in men. A clinical and histologic study.

Vázquez M, Maldonado H, Benmamán C, Sánchez JL.

Int J Dermatol. 1988 Jan-Feb;27(1):25-7.

PMID:
3346120
3.

Melasma.

Kauh YC, Zachian TF.

Adv Exp Med Biol. 1999;455:491-9.

PMID:
10599387
4.

Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma.

Grimes PE, Yamada N, Bhawan J.

Am J Dermatopathol. 2005 Apr;27(2):96-101.

PMID:
15798432
5.

Therapeutical approaches in melasma.

Prignano F, Ortonne JP, Buggiani G, Lotti T.

Dermatol Clin. 2007 Jul;25(3):337-42, viii.

PMID:
17662899
6.

Melasma in men: a clinical, aetiological and histological study.

Sarkar R, Puri P, Jain RK, Singh A, Desai A.

J Eur Acad Dermatol Venereol. 2010 Jul;24(7):768-72. doi: 10.1111/j.1468-3083.2009.03524.x. Epub 2009 Dec 15.

PMID:
20015053
7.

Melasma: histopathological characteristics in 56 Korean patients.

Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, Sohn S, Im S.

Br J Dermatol. 2002 Feb;146(2):228-37.

PMID:
11903232
8.

Mandibular melasma.

Mandry Pagán R, Sánchez JL.

P R Health Sci J. 2000 Sep;19(3):231-4.

PMID:
11076368
9.

Melasma: a clinicopathological study of 43 cases.

Sarvjot V, Sharma S, Mishra S, Singh A.

Indian J Pathol Microbiol. 2009 Jul-Sep;52(3):357-9. doi: 10.4103/0377-4929.54993.

10.

Melasma: treatment strategy.

Sehgal VN, Verma P, Srivastava G, Aggarwal AK, Verma S.

J Cosmet Laser Ther. 2011 Dec;13(6):265-79. doi: 10.3109/14764172.2011.630088. Review.

PMID:
21981383
11.

Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study.

Miot LD, Miot HA, Polettini J, Silva MG, Marques ME.

Am J Dermatopathol. 2010 Oct;32(7):676-82. doi: 10.1097/DAD.0b013e3181cd4396.

PMID:
20534990
12.

Lactic acid as a new therapeutic peeling agent in melasma.

Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA.

Dermatol Surg. 2005 Feb;31(2):149-54; discussion 154.

PMID:
15762205
13.

Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis.

Jang YH, Lee JY, Kang HY, Lee ES, Kim YC.

J Eur Acad Dermatol Venereol. 2010 Nov;24(11):1312-6. doi: 10.1111/j.1468-3083.2010.03638.x.

PMID:
20337826
14.

Characterization and evaluation of pigment distribution and response to therapy in melasma using in vivo reflectance confocal microscopy: a preliminary study.

Ardigo M, Cameli N, Berardesca E, Gonzalez S.

J Eur Acad Dermatol Venereol. 2010 Nov;24(11):1296-303. doi: 10.1111/j.1468-3083.2010.03633.x.

PMID:
20337829
15.

Two cases of melasma with unusual histopathologic findings.

Shin JH, Kang WH.

J Korean Med Sci. 2006 Apr;21(2):368-70.

16.

In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution.

Kang HY, Bahadoran P, Suzuki I, Zugaj D, Khemis A, Passeron T, Andres P, Ortonne JP.

Exp Dermatol. 2010 Aug;19(8):e228-33. doi: 10.1111/j.1600-0625.2009.01057.x.

17.

Topical liquiritin improves melasma.

Amer M, Metwalli M.

Int J Dermatol. 2000 Apr;39(4):299-301.

PMID:
10809983
18.

Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.

Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA.

Dermatol Surg. 2006 Dec;32(12):1429-36.

PMID:
17199649
19.

Q-switched alexandrite laser-assisted treatment of melasma: 2-year follow-up monitoring.

Rusciani A, Motta A, Rusciani L, Alfano C.

J Drugs Dermatol. 2005 Nov-Dec;4(6):770-4.

PMID:
16302566
20.

Histologic and ultrastructural analysis of melasma after fractional resurfacing.

Goldberg DJ, Berlin AL, Phelps R.

Lasers Surg Med. 2008 Feb;40(2):134-8. doi: 10.1002/lsm.20591.

PMID:
18306153
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk